Business Context and Reporting Period
This Form 8-K is filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc., which was the target of a recent merger) on February 24, 2023. The report addresses a change in voting eligibility for a Special Meeting of Stockholders scheduled for March 21, 2023, concerning matters related to the merger with Catheter Precision, Inc. and associated financing transactions.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting rights adjustments.
Material Changes
The primary material change concerns the voting rights of 331,608 shares of Common Stock (the "Disqualified Shares").
- Previous Status: These shares, originally purchased by Armistice Master Fund Ltd. via warrant exercise, were previously deemed ineligible to vote on Proposals 1, 2, and 3.
- Current Status: The Company was notified that these shares have been sold and are now held in the open market.
- Outcome: Following consultation with the NYSE American, the Company determined these shares are now entitled to vote on Proposals 1, 2, and 3, and their votes will not be disregarded.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary contingency addressed is the resolution of the voting eligibility dispute regarding the Disqualified Shares to ensure the Special Meeting proceeds with accurate vote counting.
Investor Verification Checklist
- Verify the date and agenda of the Special Meeting of Stockholders (March 21, 2023).
- Confirm the final voting record for Proposals 1, 2, and 3 to ensure the 331,608 shares are included.
- Review the Definitive Proxy Statement filed on February 9, 2023, for details on the merger and financing transactions.
- Check subsequent filings for the official results of the Special Meeting vote.